https://blog.google/technology/ai/bard-google-ai-search-updates/
eFFECTOR Therapeutics Collaborates With Stanford Medicine Mid-Stage Breast Cancer Study
eFFECTOR Therapeutics Inc (NASDAQ:EFTR) will collaborate with Stanford Medicine on an investigator-initiated randomized Phase 2 study evaluating zotatifin in…